A variety of scoring systems have been developed to assess NAFLD

A variety of scoring systems have been developed to assess NAFLD on the basis of simple laboratory test results in combination with other parameters. For instance, the fatty liver index predicts US-diagnosed NAFLD based on the combination of body mass index (BMI), waist circumference, and serum TAG and GGT. SteatoTest combines age, sex, and BMI with 10 laboratory determinations (AST, ALT, bilirubin, GGT, α2-macroglobulin,

apolipoprotein AI, haptoglobin, glucose, cholesterol, and TAG) to predict liver steatosis in patients with different causes of chronic liver disease (hepatitis B and C, and alcoholic and nonalcoholic liver disease), showing AUROC curves ranging from 0.72-0.86. Different scoring systems have been developed for staging fibrosis

LY2157299 in patients with NAFLD, based on the combination of age and BMI with simple laboratory measurements (glucose, Romidepsin clinical trial AST, ALT, ferritin, platelet count, and albumin) or with serum cytokines (transforming growth factor-β1, platelet-derived growth factor) and components of the extracellular matrix (collagens, collagenases and their inhibitors, glycoproteins, and polysaccharides). Of these various tests, FIB-4, NAFLD Fibrosis Score (NFS), European Liver Fibrosis (ELF), and FibroTest have been validated more amply. In general, these different scoring systems are more accurate in the detection of cirrhosis than in detecting less advanced stages of fibrosis, which limits their utility in the evaluation of fibrosis in NASH.9 US-based transient elastography (TE) imaging is a technique that can be employed to measure liver stiffness by using a probe that emits a low-frequency this website vibration and calculating the speed of the propagating mechanical wave induced by this vibration.10 In a meta-analysis of the performance of TE in the detection of hepatic fibrosis in patients with cirrhosis, this technique showed sensitivity and specificity values close to 90%. However, the performance of TE decreases in patients with less advanced fibrosis or in obese individuals. Magnetic resonance elastography is an imaging technique related to TE that visualizes, using

MRI, the speed of propagating mechanical waves. As with TE, the detection of cirrhosis by magnetic resonance elastography is highly accurate and performs better than TE in obese patients and individuals with less advanced fibrosis. A scoring system (NashTest) based on all the components of the SteatoTest and FibroTest has been developed to predict liver-diagnosed NASH, and it shows an AUROC curve of 0.79.11 The majority of the existing noninvasive NAFLD tests, such as fatty liver index, SteatoTest, or NashTest, are based on a combination of characteristics unrelated to liver function (age, BMI, sex) with biomarkers reflecting alterations in hepatic function but not directly involved in the initiation and/or progression of the liver disease (i.e., ALT, AST, GGT).

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>